Skip to main content
Free trial

Ask AI to review this stock

Copy the prompt to get recent events, historical reactions, and a short research brief.

Tell your AI:

Help me set up FinLab and analyze 3285 微端. Please read: https://finlab.finance/en/setup?stock=3285

No install, open FinLab Studio

3285

微端 Other Electronics As of 2026-06-17 Updated daily after market close

steady quality, fair valuation.

2 active signals
252d high Revenue ≥20%
This page refreshes daily after the close. Add 微端 to your watchlist to track signal changes on your next visit.
Valuation 29Quality 52Growth 96Momentum 87Chips 48

Is 微端 a buy? Fundamentals and valuation first

  • Above-average profitability.Operating margin is in the 53th market percentile. Latest quarterly ROE ≈ 2.0%.

  • Valuation is neutral.PE is in the 76th market percentile; within its own history, PE is around the 81th percentile.

  • Foreign investors are net buying.Foreign 20-day net flow ≈ 0.3% of volume (net buy).

  • Strong revenue growth.Latest monthly revenue YoY ≈ 216.8%, above the 20% growth threshold.

  • Signals are active now.On the latest data, signals such as 252-day price high, Revenue YoY ≥ 20% are active — see the historical forward returns after each occurrence below.

Chip flow

Bullish +0.84
BearishNeutralBullish

Single-sided accumulation, concentration rising — bullish

  • Single-sided accumulation, concentration rising — bullish
  • 永豐金-內湖 holds 421 lots
  • sellers have 75 lots left, ~20 sessions to clear

Window from 2026-01-17 · Price +66% · branches to 2026-06-17· TDCC to 2026-06-12

  • Largest holder 永豐金-內湖 has accumulated 421 lots since the start (sold 0%), still adding.
  • Main distributor 國泰-敦南 peaked at 113 lots, has sold 58%, 48 left, ~15 sessions to clear at the recent pace.
  • TDCC big holders (absolute) >1000-lot holders +2.59pp, mid holders +0, retail -0.74pp — concentration shifting upward.
  • Foreign hedge-desk net short Net short -49 lots (inferred from branch profile, mostly hedging — not necessarily bearish, not case-confirmed).
Branch inventory reconstruction
Accumulating holders Branches that accumulated shares during the window and still hold positive inventory; they are the absorbing side.
Distributing sellers Branches that built inventory earlier and have been selling it down; the remaining number estimates what has not cleared.
Net-short desks Trading-desk branches with negative inventory or net selling, often hedge, offsetting, or short-term flow. It is not automatically a bearish view.
Accumulating
永豐金-內湖元大-竹山國泰-台中元大-忠孝國泰-館前國票-長城
Distributing
國泰-敦南凱基-大直第一金-頭份統一-屏東宏遠-台南國票證券
Desks
own scale
聯邦商銀第一金-新竹永豐金-復興台新-嘉義
Price Accumulating & Distributing share one scale (comparable); Desks is independent. Zero is the baseline
Branch details Unit: lots

Accumulating

  • 永豐金-內湖 +421
    sold 0%· still adding
  • 元大-竹山 +141
    sold 0%· still adding
  • 國泰-台中 +114
    sold 0%· still adding
  • 元大-忠孝 +113
    sold 0%· still adding
  • 國泰-館前 +108
    sold 1%
  • 國票-長城 +102
    sold 0%· still adding

Distributing

  • 國泰-敦南 48 left
    sold 58%· ~15 sessions to clear
  • 凱基-大直 4 left
    sold 89%· ~1 sessions to clear
  • 第一金-頭份 7 left
    sold 79%· ~6 sessions to clear
  • 統一-屏東 13 left
    sold 57%· paused recently
  • 宏遠-台南 3 left
    sold 90%· ~4 sessions to clear
  • 國票證券 6 left
    sold 78%· paused recently

Desks

  • 聯邦商銀 -270
    unclassified
  • 第一金-新竹 -144
    unclassified
  • 永豐金-復興 -111
    unclassified
  • 台新-嘉義 -93
    unclassified
Still selling 75 lots ~20 sessions to bottom at most
Recent buy/sell force +1,086 absorbed / -98 sold buyers slightly ahead
TDCC big holders · absolute-holding cross-check
>1000-lot holder share Retail (<400 lots) share Price (right axis)

Direction matches: big-holder share rose while retail share fell.

Describes chip flow, not investment advice. Branch data discloses only high-volume branches with ~1-day lag; TDCC is weekly. Inventory is a relative reconstruction from the window start, not absolute holdings.

Historical evidence

Signals active now

These signals are true on the latest data, with this stock's own historical forward-return stats after each occurrence.

252-day price high (breakout)

Active

Adjusted close makes a new 252-day high; repeats within 20 days counted once.

13 historical occurrences (since 2014-08-27)
Average forward return after 252-day price high (breakout)。20-day: Win 58.3%, Sample 12, Median +5.37%, Excess +9.23%, Beat mkt rate 50%；60-day: Win 58.3%, Sample 12, Median +9.55%, Excess +8.37%, Beat mkt rate 50%；120-day: Win 58.3%, Sample 12, Median +7.55%, Excess +13.2%, Beat mkt rate 41.7%

120 days after: historical avg +20.74%

20-day +10.36%
60-day +11.77%
120-day +20.74%
20-day
60-day
120-day
Win
58.3%
58.3%
58.3%
Sample
12
12
12
Median
+5.37%
+9.55%
+7.55%
Excess
+9.23%
+8.37%
+13.2%
Beat mkt rate
50%
50%
41.7%

Over 12 occurrences, 120-day forward avg gained 20.74%, beat the market by 13.2 pts; win rate 58.3%.

Monthly revenue YoY ≥ 20% (from filing deadline)

Active · now 216.75%

Monthly revenue YoY ≥ 20%; event date is the first trading day after the filing deadline (no look-ahead).

58 historical occurrences (since 2012-07-23)
Average forward return after Monthly revenue YoY ≥ 20% (from filing deadline)。20-day: Win 50%, Sample 42, Median -0.01%, Excess +2.45%, Beat mkt rate 42.9%；60-day: Win 34.1%, Sample 41, Median -2.61%, Excess -3.14%, Beat mkt rate 34.1%；120-day: Win 39.5%, Sample 38, Median -5.79%, Excess -4.4%, Beat mkt rate 31.6%

120 days after: historical avg +1.44%

20-day +3.89%
60-day +0.91%
120-day +1.44%
20-day
60-day
120-day
Win
50%
34.1%
39.5%
Sample
42
41
38
Median
-0.01%
-2.61%
-5.79%
Excess
+2.45%
-3.14%
-4.4%
Beat mkt rate
42.9%
34.1%
31.6%

Over 38 occurrences, 120-day forward avg gained 1.44%, lagged the market by 4.4 pts; win rate 39.5%.

Valuation regime and subsequent returns

Each day's PE is converted to its own-history percentile (as of that day), then we look at adjusted-close returns over the next 240 trading days by valuation regime.

PE percentile bandSample days240-day avg returnMedianWin rateAvg excess (vs index)
0-20 3180% -3.1% 42.5% -18.6%
20-40 358-6% -11.9% 42.2% -22.4%
40-60 487+1.6% -3.8% 45% -25.6%
60-80 487+3% +1.8% 57.3% -14.4%
80-100 You are here280+37.5% +36.6% 95.4% -8.8%

Percentiles use an expanding own-history window (no look-ahead); forward return is 240 trading days on adjusted close. Sample days overlap; distribution is indicative only.

Current PE ≈ 49.68, at the 80.9th percentile of its own history (80-100 band).

Valuation × momentum historical grid

Every day in its own history is bucketed by valuation tercile (own-history PE) and 60-day momentum sign into six cells; we show adjusted-close returns over the next 120 trading days per cell.

Valuation
Momentum
Cheap (own-history bottom 1/3)
Mid
Expensive (own-history top 1/3)
60-day momentum up
-13.2%
Win rate 2.9% Excess -20%
140d
-8.4%
Win rate 15.8% Excess -12.3%
360d
Now
+10.4%
Win rate 75.8% Excess -9.1%
417d
60-day momentum down
+1.5%
Win rate 42.9% Excess -7.9%
382d
-1.2%
Win rate 38.9% Excess -9.7%
517d
+29.3%
Win rate 87.9% Excess +2.1%
232d

Currently in “Expensive (own-history top 1/3) × 60-day momentum up”: across 417 historical days, 120-day forward avg gained 10.4%, win rate 75.8%, lagged the market by 9.1%.

Days = trading days in this bucket; returns use adjusted prices, ex-costs. 60-day momentum: direction of this stock's price over the past 60 trading days.

Does this signal hold up across the market

Over the past 242 months, on average ~404 stocks per month met “monthly revenue YoY ≥ 20%”; their adjusted-close return over the next 60 trading days averaged 6.94% (equal-weighted), beating the market by 2.37 points on average, and outperformed the TAIEX total-return index in 64.5% of months.

Each month, equal-weighted 60-day forward adjusted return of all signal-matching stocks, then averaged across months; excess vs the TAIEX total-return index.

Signals not active (historical stats for reference)

These are not occurring now; historical samples shown for comparison.

Foreign net buying for 5 straight days

Pending

Foreign net flow (ex-dealer) positive for 5 straight days; event on day 5; repeats within 20 days counted once.

32 times historically; 60-day forward avg +3.96%, win rate 56.2%, beating the market by +2.16 pts on average.

What does 微端 do? Company profile

其他電子業；櫃買中心產業鏈歸類為電腦及週邊設備／其他電腦及週邊設備 上櫃（櫃買中心）

Overview

3285 對應證券為微端科技股份有限公司，英文名 Microtips Technology Inc.，為櫃買中心上櫃普通股，非 ETF、ETN、權證或特別股。公司成立於 1995 年 7 月 27 日，2012 年 7 月 23 日上櫃，總部位於新北市汐止區康寧街 169 巷 31 號 12 樓，統一編號 89649873，電話 (02)2692-3889。依 2026 年刊印之 114 年報與公開資料，董事長為陳曉華，總經理為魯景岱，發言人為楊宗達，股本為新台幣 427,353,240 元，已發行普通股 42,735,324 股。員工規模：2024 年 195 人、2025 年 190 人、截至 2026/3/31 為 176 人。主要股東名單（2026/4/13）：鴻利投資 13.66%、香港商連達亞太台灣分公司 9.85%、勝煒投資 9.55%、璟均國際 4.96%、村晟投資顧問 3.20%、魯景明 2.59%、台新銀行受託信託財產專戶 2.52%、吳蕙妤 2.38%、吳建勳 2.33%、吳建辰 2.33%。關係企業包括 Microtips Technology LLC（美國，持股 59.33%）、Microtips (H.K.) Technology Limited（100%）、勝維智國際有限公司（香港，100%）、M-Tech Int’l Group Inc.（BVI，100%）、微端智能股份有限公司（100%）、勝維精密股份有限公司（20%）。

Business

公司定位為人機介面與電子產品 OEM/ODM 製造商，核心產品為液晶顯示模組、數位影音多媒體產品、軍警用設備、智能化資料開發服務與血液加溫器主板／醫療器材代工。2025 年（114 年度）合併營收新台幣 678,576 仟元，產品營收比重：液晶顯示模組 308,852 仟元、45.52%；數位影音多媒體產品 184,934 仟元、27.25%；軍警用設備 39,165 仟元、5.77%；智能化設備 30,314 仟元、4.47%；血液加溫器產品 23,807 仟元、3.51%；其他 91,504 仟元、13.48%。液晶顯示模組包含 STN LCM、TFT LCM，應用於醫療、通訊、辦公室自動化、工業控制、工控、車載與專業設備顯示。數位音效產品用於專業音樂錄音室、廣播電台、演唱會、網路直播等，產品包括音效處理器、混音器、擴大器、錄音器材與相關軟體。軍警用設備包含警用配戴式攝影機、執法影像設備、證據收集相機，強調加密、授權、影像蒐證與法院證據用途。智能化資料開發服務以智慧機上盒連結生產設備，提供資料採集、工業通訊協定轉換、MES/ERP 串接、可視化、邊緣運算與智慧製造資料分析。血液加溫器產品為醫療級電子控制模組與 PCBA 代工，服務以色列客戶之移動式／臨床式血液或輸液加溫器，終端市場以美國急救、手術、軍醫與大量輸血場景為主。商業模式以 OEM/ODM、客製化共同開發、少量多樣與工程協同設計為主，重視品質、交期、測試驗證、安規與醫療法規合規能力。2025 年主要銷貨客戶為 Fender 16%、Oracle 9%、其他 75%；2026 年第一季主要銷貨客戶為 Fender 19%、威至科技 9%、其他 72%。

Outlook 2025–2028

2025 年營運結果顯示，公司合併營收 6.79 億元、EPS 0.7 元，較 2024 年營收 8.45 億元下滑，但產品組合中 LCM 仍為最大收入來源，數位影音與醫療代工為重要變動項。2025 至 2028 年展望可分五條主軸：一、LCM：LCD 大規模資本投資趨於保守，但中小尺寸、客製化、高亮度、廣溫、低功耗、觸控整合與工控／醫療／車載／專業應用仍有利基需求，公司以高附加價值專用型模組、製程穩定與客製服務維持現金流。二、數位音效：與品牌大廠共同開發音效介面、效果器電源、踏板等新項目，成長動能來自專業音訊、直播、內容創作與品牌 OEM 專案，但需面對中國組裝廠比價與客戶產品互斥，客戶集中與新專案取得節奏會影響營收。三、軍警設備：全球執法記錄器需求受透明執法、證據保存、即時傳輸、AI 影像辨識、資料安全帶動，公司投入長續航、高畫質、無線傳輸、後台系統與子彈鑑識攝影工具；但此市場由 Axon、Motorola Solutions、Digital Ally、Reveal、Getac 等國際品牌主導，微端較可能扮演特定客戶 OEM/ODM 與客製製造角色。四、智能化設備：智慧工廠、IoT、AI、邊緣運算、低代碼工具與資料可視化將支撐需求，公司智慧盒可應用於 PCB、IC 載板、車載 PCB 與其他製造場域，但此領域需大量需求訪談、安裝調試與系統整合，專案型營收波動較大。五、血液加溫器：公司與以色列客戶合作，受美國市場與緊急醫療、EMS、軍醫需求帶動；年報引用外部研究稱 2026 年全球血液加溫器市場約 18 億美元、2026-2035 CAGR 約 6.43%，北美約占四成，若客戶通路擴張順利，微端醫療代工有望成為 2026-2028 高附加價值成長點。主要風險包括：美元匯率波動、原物料與物流成本、美國關稅不確定性、客戶訂單波動、低價競爭、醫療法規與品質系統門檻、資安風險、天災與供應鏈中斷。公司因應策略包括自然避險、策略性安全庫存、越南生產方案以分散中國／台灣產地與關稅風險、提高自動化、強化醫療級可靠度測試與法規能力。

Supply Chain

Upstream
  • 億力光電股份有限公司 LCD 供應商；年報列為主要原料 LCD 供應來源，供應狀況良好；公開資料顯示非上市櫃或未上市櫃性質，故 stock_id 依規則填 null。
  • 富相科技股份有限公司 LCD 供應商；年報列為主要原料 LCD 供應來源，供應狀況良好；公開發行但非上市櫃，故 stock_id 填 null。
  • Spin IC 供應商；年報列為數位音效產品 IC 供應來源，供應狀況良好；未確認為台股上市櫃公司。
  • 如陽電子 IC 供應商；年報列為數位音效產品 IC 供應來源，供應狀況良好；未確認為台股上市櫃公司。
  • 安富利 Avnet IC／電子零組件通路供應商；美國上市公司，非台股上市櫃，故 stock_id 填 null。
  • 力群電子股份有限公司 T/P 觸控面板供應商；年報列為供應來源，供應狀況良好；公開發行但非上市櫃，故 stock_id 填 null。
  • 勁高科技 T/P 供應商；年報列為供應來源，供應狀況良好；未確認為台股上市櫃公司。
  • 恒揚光電 B/L 背光模組供應商；年報列為供應來源，供應狀況良好；未確認為台股上市櫃公司。
  • 金協昌 PCB 供應商；年報列為供應來源，供應狀況良好；未確認為台股上市櫃公司。
  • 蘇菲克企業 PCB 供應商；年報列為供應來源，供應狀況良好；未確認為台股上市櫃公司。
  • 研華股份有限公司 2395 智慧盒／工業電腦相關供應商；年報列為智能化設備供應來源，供應狀況良好；台股上市公司。
  • 美綠 智慧盒供應商；年報列為智能化設備供應來源，供應狀況良好；未確認為台股上市櫃公司。
  • 鴻寶科技 恆溫恆壓控制熱水桶供應商；年報列為其他主要原料供應來源，供應狀況良好；未確認為台股上市櫃公司。
Downstream
  • Fender 主要銷貨客戶；2025 年銷貨 107,112 仟元、占 16%，2026 年第一季占 19%；美國樂器與音響品牌，非台股上市櫃。
  • Oracle 2025 年主要銷貨客戶，銷貨 59,870 仟元、占 9%；美國上市公司，非台股上市櫃。
  • 亞弘電科技股份有限公司 6201 2024 年主要銷貨客戶之一，銷貨 56,325 仟元、占 8%；台股上市櫃公司。
  • 威至科技 2026 年第一季主要銷貨客戶之一，占 9%；未確認為台股上市櫃公司。
  • QinFlow／以色列醫療器材客戶 年報敘述公司與以色列客戶合作代工移動式血液加溫器，並提及 QinFlow 在北美 EMS／軍醫通路布局；非台股上市櫃。
  • 國內外通路商、專業音響器材行、專業音響連鎖店 數位音效產品下游通路與終端銷售環節；非單一台股上市櫃公司。
  • 工控、醫療設備、車載系統、辦公室自動化與通訊設備廠商 LCM 下游應用產業；多為客製化 OEM/ODM 客戶，年報未逐一揭露公司名稱。
  • 警政、軍事、私人保全與執法設備品牌商 軍警用攝影機與證據收集相機下游應用；多為專案或品牌客戶，年報未逐一揭露台股公司名稱。

Competitors

  • 光聯科技股份有限公司 5315 台股上櫃公司；LCD／LCM 相關同業，可視為液晶顯示模組利基市場競爭者。
  • 眾福科技股份有限公司 3168 台股上櫃公司；顯示器與 LCD 相關產品同業，與微端 LCM 業務具部分競爭或替代關係。
  • 全台晶像股份有限公司 3038 台股上市公司；LCD 顯示器相關同業，屬顯示模組／顯示產品供應鏈競爭參考。
  • 義發科技股份有限公司 台股上櫃公司；LCD／LCM 相關同業，屬微端顯示模組業務競爭參考。
  • 聯友光電股份有限公司 台股上櫃公司；LCD／LCM 相關同業，屬顯示模組競爭參考。
  • 晶睿通訊股份有限公司 3454 台股上市公司；網路攝影機與安防影像設備供應商，與微端軍警攝影／影像設備在安防影像終端應用有間接競爭。
  • 奇偶科技股份有限公司 3356 台股上櫃公司；影像監控與安防系統廠商，與微端軍警影像設備在安全監控應用有間接競爭。
  • 研華股份有限公司 2395 台股上市公司；工業電腦、IoT、智慧工廠平台龍頭，與微端智能化設備／智慧盒服務在工業資料採集與邊緣設備有部分競爭，也同時可能是供應鏈合作對象。
  • Axon Enterprise 美國上市公司；全球執法記錄器與警用影像平台主要品牌，非台股上市櫃。
  • Motorola Solutions 美國上市公司；警用通訊、影像與公共安全平台主要供應商，非台股上市櫃。
  • 3M Company 美國上市公司；年報列為美國血液與靜脈輸液加溫設備主要競爭者之一，非台股上市櫃。
  • ICU Medical / Smiths Medical 美國上市公司／醫療器材品牌；年報列為血液與輸液加溫設備主要競爭者，非台股上市櫃。
  • Stryker Corporation 美國上市公司；年報列為血液加溫器相關競爭者之一，非台股上市櫃。
  • Baxter International 美國上市公司；年報列為血液加溫器相關競爭者之一，非台股上市櫃。
  • Belmont Medical Technologies 美國醫療器材公司；血液與輸液加溫設備競爭者，非台股上市櫃。
Sources（18）

This company profile is compiled from public sources (annual reports, filings, news and analyst reports), not finlab backtest data; the 2025–2028 outlook contains forward-looking estimates and is for reference only.

Method and limitations

  • All returns use adjusted close (etl:adj_close), already adjusted for dividends and splits.
  • Excess return is measured against the TAIEX total-return index (dividends included).
  • Valuation regime and percentile stats use an expanding own-history window (no future data).
  • Revenue-signal event dates align to the first trading day after the filing deadline, avoiding look-ahead.
  • Event samples may overlap in time; stats describe historical distribution only and are less reliable when samples are few.

This page is historical statistics for educational purposes and is not investment advice. Investing involves risk; past performance does not indicate future results. Assess and bear the risk yourself before trading.